- Medical Device
- National Institutes of Health
- Rush University Medical Center
- Eli Lilly & Co.
- Avid Radiopharmaceuticals Inc.
- Cleveland Clinic
- Pfizer Inc.
- Johnson & Johnson
- Bristol-Myers Squibb Co.
- Lilly Research Laboratories
- Quintiles Transnational Holdings Inc.
- Janssen Pharmaceutica NV
- General Electric Co.
- GE Healthcare
- Abbott Laboratories Inc.
- Clarient Inc.
- Takeda Pharmaceutical Co. Ltd.
- Zinfandel Pharmaceuticals Inc.
- Novartis AG
- Novartis Pharmaceuticals Corp.
- Orasi Medical Inc.
- University of Minnesota
- GlaxoSmithKline PLC
- Cognoptix Inc.
- Functional Neuromodulation Ltd.
- Diaxonhit SA
- Molecular Targeting Technologies Inc.
- University of Notre Dame
- Scripps Research Institute
- Eli Lilly to buy Avid for $300mm up front plus earn-outs
- TPG-Axon provides Eli Lilly with funds for Alzheimer's trials
- GE buys Abbott's POC, diagnostics units for $8bn; withdrawn
- GE to buy Clarient for $587mm
- Zinfandel grants Takeda exclusive rights to Alzheimer’s disease biomarker
- Novartis partners with Orasi for CNS biomarker
- First Series C tranche brings $4.6mm to Neuroptix
- MTTI licenses cell-sensing technology from Notre Dame
Ask The Analyst
Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst
Your question has been successfully sent to the email address below and we will get back as soon as possible. firstname.lastname@example.org.
All fields are required.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.